Nynomic AG (M7U.DE)
EUR 18.3
(0.27%)
EUR 18.3
(0.27%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 2.35 Million | 9.67 Million | 17.83 Million | 6.36 Million | 3.55 Million | 2.17 Million |
| Net Income | 9.3 Million | 9.94 Million | 9.51 Million | 5.18 Million | 4.29 Million | 7.55 Million |
| Depreciation & Amortization | 4.78 Million | 4.09 Million | 4 Million | 3.46 Million | 3.12 Million | 3.15 Million |
| Deferred income taxes | - | -30 Thousand | -93 Thousand | - | - | - |
| Stock-based compensation | 35 Thousand | 30 Thousand | 93 Thousand | - | - | - |
| Change in working capital | -11.84 Million | -5.49 Million | 2.91 Million | -4.18 Million | -3.5 Million | -8.9 Million |
| Other non-cash items | 11.65 Million | 1.13 Million | 1.39 Million | 1.9 Million | -356 Thousand | 374.16 Thousand |
| Investing Cash Flow | -13.78 Million | -2.55 Million | -5.32 Million | -6.95 Million | -6.57 Million | -25.42 Million |
| Investments in PPE | -8.71 Million | -2.57 Million | -1.43 Million | -1.86 Million | -2.07 Million | -1.73 Million |
| Acquisitions | - | - | -3.91 Million | -5.11 Million | -4.53 Million | -24.41 Million |
| Investment purchases | -5.07 Million | - | - | - | - | -24.41 Million |
| Sales/Maturities of investments | - | - | - | - | - | 678.5 Thousand |
| Other Investing Activities | -11.17 Million | 21 Thousand | 26 Thousand | 22 Thousand | 29 Thousand | -24.36 Million |
| Financing Cash Flow | 6.9 Million | -7.53 Million | -9.15 Million | 12.26 Million | 1.7 Million | 14.32 Million |
| Debt repayment | -7.41 Million | -4.43 Million | -6.23 Million | -4.59 Million | -3.05 Million | -1.86 Million |
| Dividends payments | -2.06 Million | -432 Thousand | -737 Thousand | -621 Thousand | -746 Thousand | -1.65 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 18.97 Million | 408 Thousand | 605 Thousand | 13.41 Million | - | - |
| Other Financing Activities | -2.06 Million | -3.07 Million | -2.78 Million | 4.07 Million | 5.5 Million | 17.84 Million |
| Accounts receivables | - | -6.12 Million | -6.13 Million | -806 Thousand | 144 Thousand | - |
| Accounts payables | -1.97 Million | 6.12 Million | 6.13 Million | 806 Thousand | -144 Thousand | -949 Thousand |
| Inventory | -9.94 Million | -11.89 Million | -4.1 Million | -4.67 Million | -1.03 Million | -7.05 Million |
| Other working capital | -9.86 Million | 6.39 Million | 7.01 Million | 492 Thousand | -2.47 Million | -1.85 Million |
| Cash at beginning of period | 26.6 Million | 26.74 Million | 22.11 Million | 10.64 Million | 11.07 Million | 19.46 Million |
| Cash at end of period | 21.86 Million | 26.6 Million | 26.74 Million | 22.11 Million | 10.64 Million | 10.87 Million |
| Capital Expenditure | -8.71 Million | -2.57 Million | -1.43 Million | -1.86 Million | -2.07 Million | -1.73 Million |
| Effect of forex changes on cash | -209 Thousand | 262 Thousand | 626 Thousand | -214 Thousand | 39 Thousand | 134.06 Thousand |
| Net cash flow / Change in cash | -4.73 Million | -145 Thousand | 4.63 Million | 11.47 Million | -434 Thousand | -8.58 Million |
| Free Cash Flow | -6.36 Million | 7.1 Million | 16.39 Million | 4.5 Million | 1.48 Million | 439.69 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.44 Million | 1.44 Million | 9.3 Million | 6.57 Million | 3.28 Million | 2.73 Million |
| Depreciation & Amortization | 1.22 Million | 1.22 Million | 4.78 Million | 2.51 Million | 1.25 Million | 2.26 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | 35 Thousand | 17.5 Thousand | 17.5 Thousand | - |
| Change in working capital | -1.44 Million | -1.44 Million | -11.84 Million | 771 Thousand | 199.5 Thousand | -12.61 Million |
| Other non-cash items | -951 Thousand | -951 Thousand | 11.65 Million | 6.29 Million | 1.18 Million | 5.35 Million |
| Investing Cash Flow | -1.47 Million | -1.47 Million | -13.78 Million | -12.1 Million | -5.95 Million | -1.67 Million |
| Investments in PPE | -1.09 Million | -1.09 Million | -8.71 Million | -675 Thousand | -337.5 Thousand | -1.67 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -810 Thousand | - | -5.07 Million | -5.07 Million | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -378 Thousand | -378 Thousand | -11.17 Million | -5.61 Million | -5.61 Million | 31 Thousand |
| Financing Cash Flow | -2.28 Million | -2.28 Million | 6.9 Million | -2.11 Million | -1.36 Million | 9.02 Million |
| Debt repayment | -2.19 Million | - | -7.41 Million | -1.21 Million | - | -8.62 Million |
| Dividends payments | - | - | -2.06 Million | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 18.97 Million | 95 Thousand | - | 18.88 Million |
| Other Financing Activities | -2.28 Million | -2.28 Million | -2.06 Million | -2.06 Million | -1.36 Million | 4.27 Million |
| Accounts receivables | - | - | - | - | - | 4.78 Million |
| Accounts payables | -1.45 Million | - | -1.97 Million | 372 Thousand | - | -2.35 Million |
| Inventory | -1.19 Million | -1.19 Million | -9.94 Million | -183.5 Thousand | -183.5 Thousand | -4.78 Million |
| Other working capital | -245 Thousand | -245 Thousand | -9.86 Million | 399 Thousand | 383 Thousand | -10.26 Million |
| Cash at beginning of period | 21.86 Million | - | 26.6 Million | 24.61 Million | - | 26.6 Million |
| Cash at end of period | 15.4 Million | -3.41 Million | 21.86 Million | 21.86 Million | -1.37 Million | 24.61 Million |
| Capital Expenditure | -1.09 Million | -1.09 Million | -8.71 Million | -675 Thousand | -337.5 Thousand | -1.67 Million |
| Effect of forex changes on cash | 54.5 Thousand | 54.5 Thousand | -209 Thousand | -3500.00 | -3500.00 | -101 Thousand |
| Net cash flow / Change in cash | -6.45 Million | -3.41 Million | -4.73 Million | -2.74 Million | -1.37 Million | -1.99 Million |
| Free Cash Flow | -807.5 Thousand | -807.5 Thousand | -6.36 Million | 10.81 Million | 5.61 Million | -10.81 Million |
2371
2020
CELL
GEVO
ALNMR
4187